Scribe Biosciences
About:
Flexible tools for single cell analysis
Website: https://www.scribebiosciences.com/
Top Investors: National Science Foundation, Casdin Capital, Formic Ventures, Harmonix Fund, BioTools Innovator
Description:
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
$3.13M
$1M to $10M
San Francisco, California, United States
2017-09-01
info(AT)scribebiosciences.com
Adam Abate, Maithreyan Srinivasan, Russell Cole, Zev Gartner
11-50
2023-06-06
Private
© 2025 bioDAO.ai